Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Adenocarcinoma, Papillary

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Adenocarcinoma, Papillary in 1 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Adenocarcinoma, Papillary: An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yuan, ZQ1
Sun, M1
Feldman, RI1
Wang, G1
Ma, X1
Jiang, C1
Coppola, D1
Nicosia, SV1
Cheng, JQ1

Other Studies

1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Adenocarcinoma, Papillary

ArticleYear
Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer.
    Oncogene, 2000, May-04, Volume: 19, Issue:19

    Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adenosarcoma; Amino Acid Sequence; Apoptosis; B

2000